Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiovascular Imaging Reports
Published in: Current Cardiovascular Imaging Reports 1/2013

01-02-2013 | Molecular Imaging (ZA Fayad, Section Editor)

MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements

Authors: Amy W. Pollak, Christopher M. Kramer

Published in: Current Cardiovascular Imaging Reports | Issue 1/2013

Login to get access

Abstract

Evaluation of peripheral arterial disease by cardiovascular magnetic resonance imaging continues to develop. Of the clinical diagnostics tests currently available, magnetic resonance angiography is well established as one of the preferred techniques for determining areas of arterial occlusive disease affecting the lower extremities. Despite this, there have been new developments in non-gadolinium based contrast-enhanced studies as well as testing done at higher field strength scanners. In the research arena, magnetic resonance spectroscopy, calf muscle perfusion imaging and atherosclerotic plaque evaluation all have made significant advancements over the last year. These techniques are gaining traction as surrogate endpoints in clinical trials of novel therapeutics aimed at alleviating symptoms in patients with peripheral arterial disease.
Literature
1.
Rajagopalan S, Mihai G. Perspectives on optimizing trial design and endpoints in peripheral arterial disease: a case for imaging-based surrogates as endpoints of functional efficacy. Cardiol Clin. 2011;29(3):419–31.PubMedCrossRef
2.
Kribben A, Witzke O, Hillen U, et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis and therapy. J Am Coll Cardiol. 2009;53:1621–8.PubMedCrossRef
3.
Nielsen YW, Thomsen HS. Contrast-enhanced peripheral MRA: technique and contrast agents. Acta Radiologica. 2012;53:769–77.PubMedCrossRef
4.
• Malcolm PN, Lewis M. Prospective studies show that magnetic resonance angiography has high sensitivity and specificity for clinically relevant arterial steno-occlusions in adults with peripheral arterial disease symptoms. Evid Based Med. 2011;16:90–1. This is a well written review of the prospective studies for MRA used in PAD affecting the lower extremities.PubMedCrossRef
5.
van den Bosch H, Westenberg J, Duijm L, et al. 3 T versus 1.5 T MR angiography in peripheral arterial occlusive disease: an equivalence trial in comparison with digital subtraction angiography. J Cardiovas Magn R. 2012;14:139.CrossRef
6.
Plank C, Wolf F, Langenberger H, et al. Improved detection of in-stent restenosis by blood pool agent-enhanced, high-resolution, steady-state magnetic resonance angiography. Eur Radiol. 2011;21:2158–65.PubMedCrossRef
7.
Li J, Zhao JG, Li MH. Lower limb vascular disease in diabetic patients: a study with calf compression contrast-enhanced magnetic resonance angiography at 3.0 Tesla. Acad Radiol. 2011;18(6):755–63.PubMedCrossRef
8.
• Miyazaki M, Akahane M. Non-contrast enhanced MR angiography: established techniques. J Magn Reson Imaging. 2012;35:1–19. Thorough review of the current non-contrast enhanced MRA techniques.PubMedCrossRef
9.
Wedeen VJ, Meuli RA, Edelman RR, et al. Projective imaging of pulsatile flow with magnetic resonance. Science. 1985;230:946–8.PubMedCrossRef
10.
Mihai G, Chung YC, Merchant A, Simonetti OP, Rajagopalan S. T1-weighted – SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience. J Magn Reson Imaging. 2010;31:502–9.PubMedCrossRef
11.
Edelman RR, Sheehan JJ, Dunkle E, et al. Quiescent-interval single-shot unenhanced magnetic resonance angiography of peripheral vascular disease: technical considerations and clinical feasibility. Magn Reson Med. 2010;63:951–8.PubMedCrossRef
12.
Offerman EJ, Koktzoglou I, Glielmi C, Sen A, Edelman RR. Prospective self-gated nonenhanced magnetic resonance angiography of the peripheral arteries. Magn Reson Med. 2012. doi:10.​1002/​mrm.​24240.
13.
• Hodnett PA, Koktzoglou I, Davarpanah AH, et al. Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography. Radiology. 2011;260:282–93. This is an important area of development for NC-MRA.PubMedCrossRef
14.
Klasen J, Blondin D, Schmitt P, et al. Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA. Clin Radiol. 2012;67:441–6.PubMedCrossRef
15.
Haneder S, Attenberger U, Riffel P, et al. Magnetic resonance angiography (MRA) of the calf station at 3.0-T: intraindividual comparison of non-enhanced ECG-gated flow-dependent MRA, continuous table movement MRA and time-resolved MRA. Euro Radiol. 2011;21:1452–61.CrossRef
16.
Williams DM, Fencil L, Chenevert TL. Peripheral arterial occlusive disease: P-31 MR spectroscopy of calf muscle. Radiology. 1990;175(2):381–5.PubMed
17.
Gorny O, Santner W, Fraedrich G, et al. The run-off resistance (ROR) assessed on MR angiograms may serve as a valid scoring system in patients with symptomatic peripheral arterial disease (PAD) and correlates with the ankle-brachial pressure index (ABI). Euro J Radiol. 2012;81(6):1155–7.CrossRef
18.
Isbell DC, Epstein FH, Zhong X, et al. Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first pass contrast-enhanced magnetic resonance imaging. J Mag Reson. 2007;25:1013–20.CrossRef
19.
Jiji RS, West AM, Epstein FH, et al. Reproducibility of contrast-enhanced calf muscle perfusion MRI measures in peripheral arterial disease. Circulation. 2011;124:A11374.
20.
Versluis B, Backes WH, van Eupen MGA, et al. Magnetic resonance imaging in peripheral arterial disease: reproducibility of the assessment of morphological and functional vascular status. Invest Radiol. 2011;46:11–24.PubMedCrossRef
21.
Versluis B, Dremmen MHG, Nelemans PJ, et al. MRI of arterial flow reserve in patients with intermittent claudication: feasibility and initial experience. PLoS One. 2012;7:e31514.PubMedCrossRef
22.
Detre JA, Zhang W, Roberts DA, et al. Tissue specific perfusion imaging using arterial spin labeling. NMR Biomed. 1994;7:75–82.PubMedCrossRef
23.
Wu W-C, Mohler E, Ratcliffe SJ, et al. Skeletal muscle microvascular flow in progressive peripheral arterial disease: assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. J Am Coll Cardiol. 2009;53:2372–7.PubMedCrossRef
24.
West AM, Meyer CH, Epstein FH, et al. Arterial spin labeling MRI reproducibly measures peak-exercise calf muscle perfusion in healthy volunteers and patients with peripheral vascular disease. JACC Cardiovasc Imag. 2012; in press.
25.
Ledermann H, Schulte AC, Heidecker HG, et al. Blood oxygenation level dependent magnetic resonance imaging of the skeletal muscle in patients with peripheral arterial occlusive disease. Circulation. 2006;113:2929–35.PubMedCrossRef
26.
Partovi S, Karimi S, Jacobi S, et al. Clinical implications of skeletal muscle blood-oxygen-level-dependent (BOLD) MRI. MAGMA. 2012;25(4):251–61.PubMedCrossRef
27.
Isbell DC, Berr SS, Toledano AY, et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol. 2006;47:2289–95.PubMedCrossRef
28.
West AM, Anderson JD, Epstein FH, et al. Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study. Vasc Med. 2012;17:3–9.PubMedCrossRef
29.
West AM, Anderson JD, Epstein FH, et al. LDL lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol. 2011;58:1068–76.PubMedCrossRef
30.
Wu JS, Buettner C, Smithline H, Ngo LH, Greenman RL. Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle Nerve. 2011;43:76–81.PubMedCrossRef
31.
Andreas M, Schmid A, Keilani M, et al. Effect of ischemic preconditioning in skeletal muscle measured by functional magnetic resonance imaging and spectroscopy: a randomized crossover trial. J Cardiovasc Magn Reson. 2011;13:32.PubMedCrossRef
32.
Befroy DE, Shulman GI. Magnetic resonance spectroscopy studies of human metabolism. Diabetes. 2011;60:1361–9.PubMedCrossRef
33.
• Balu N, Wang J, Dong L, et al. Current techniques for MR imaging of atherosclerosis. Top Magn Reson Imag. 2009;20(4):203–15. This is an excellent review of the current techniques for evaluation of atherosclerosis using CMR.CrossRef
34.
Isbell DC, Meyer CH, Rogers WJ, et al. Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2007;9:71–6.PubMedCrossRef
35.
West AM, Anderson JD, Meyer CH, et al. The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis. 2011;218:156–62.PubMedCrossRef
36.
McDermott MM, Liu K, Carroll TJ, et al. Superficial femoral artery plaque and functional performance in peripheral arterial disease: Walking and Leg Circulation Study (WALCS III). JACC: Cardiovasc Imag. 2011;4:730–9.CrossRef
37.
Bourque JM, Schietinger BJ, Kennedy JL, et al. Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis. Am J Cardiol. 2012;110:50–6.PubMedCrossRef
38.
Bianda N, Di Valentino M, Periat D, et al. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging. Eur Heart J. 2012;33:230–7.PubMedCrossRef
39.
Brown R, Karmonik C, Brunner G, et al. Simultaneous bilateral magnetic resonance imaging of the femoral arteries in peripheral arterial disease patients. J Magn Reson Imag. 2011;34:150–6.CrossRef
40.
Chiu B, Sun J, Wang J, et al. Fast plaque burden assessment of the femoral artery using 3D black blood MRI and automated segmentation. Med Phys. 2011;38:5370–84.PubMedCrossRef
41.
Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368–73.PubMedCrossRef
42.
Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscl Throm Vasc. 2005;25:234–9.
43.
Fayad ZA, Nahar T, Fallon JT, et al. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta. Circulation. 2000;101:2503–9.PubMedCrossRef
44.
Li F, McDermott MM, Li D, et al. The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: a high-spatial-resolution, multi-contrast weighted CMR study. J Cardiovasc Magn Reson. 2010;12:37.PubMedCrossRef
45.
McAteer MA, Schneider JE, Ali ZA, et al. Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide. Arterioscl Throm Vasc. 2008;28:77–83.CrossRef
46.
Mitsumori LM, Ricks JL, Rosenfeld ME, Schmiedl UP, Yuan C. Development of a lipoprotein based molecular imaging MR contrast agent for the noninvasive detection of early atherosclerotic disease. Int J Cardiovasc Imag. 2004;20:561–7.CrossRef
47.
Frias JC, Williams KJ, Fisher EA, Fayad ZA. Recombinant HDL-like nanoparticles: a specific contrast agent for mri of atherosclerotic plaques. J Am Chem Soc. 2004;126:16316–7.PubMedCrossRef
48.
Myers KS, Rudd JHF, Hailman EP, et al. Correlation between arterial fdg uptake and biomarkers in peripheral artery disease. JACC: Cardiovasc Imag. 2012;5:38–45.CrossRef
Metadata
Title
MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements
Authors
Amy W. Pollak
Christopher M. Kramer
Publication date
01-02-2013
Publisher
Current Science Inc.
Published in
Current Cardiovascular Imaging Reports / Issue 1/2013
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-012-9175-z

Other articles of this Issue 1/2013

Current Cardiovascular Imaging Reports 1/2013 Go to the issue

Molecular Imaging (ZA Fayad, Section Editor)

Magnetic Resonance Imaging of Carotid Atherosclerosis and the Risk of Stroke

Molecular Imaging (ZA Fayad, Section Editor)

Lipid-Based Nanoparticles in Cardiovascular Molecular Imaging

Molecular Imaging (ZA Fayad, Section Editor)

Cardiac Magnetic Resonance Imaging: Recent Advances and New Insights in Cardiovascular Disease

Molecular Imaging (ZA Fayad, Section Editor)

Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis

Molecular Imaging (ZA Fayad, Section Editor)

Molecular MRI of the Cardiovascular System in the Post-NSF Era

Molecular Imaging (ZA Fayad, Section Editor)

Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits